Global mRNA Vaccines & Therapeutics Market Analysis 2017-2021 and Forecast 2021-2027

  • Published Date : 24-11-2021
  • Pages : 112
  • Report Id : 30803
  • Categories : Healthcare



The global mRNA Vaccines & Therapeutics market size is estimated at xxx million USD with a CAGR xx% from 2017-2021 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2027. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of mRNA Vaccines & Therapeutics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Argos Therapeutics
AstraZeneca
Bayer
BioNTech
Boehringer Ingelheim
CRISPR Therapeutics
CureVac
eTheRNA immunotherapies
Ethris
GlaxoSmithKline Vaccines
In-Cell-Art
Intellia Therapeutics
Janssen
Kernal Biologics
MaxCyte
Moderna Therapeutics
Novartis
PhaseRx
Precision NanoSystems
RaNa Therapeutics

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospital
Clinic
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
1 Industry Overview
1.1 mRNA Vaccines & Therapeutics Industry
Figure mRNA Vaccines & Therapeutics Industry Chain Structure
1.1.1 Overview
1.1.2 Development of mRNA Vaccines & Therapeutics
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of mRNA Vaccines & Therapeutics
1.2.2 Downstream
Table Application Segment of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Market 2017-2027, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 mRNA Vaccines & Therapeutics Market by Type
3.1 By Type
3.1.1 Standardization Of Cancer Treatment MRNA Vaccine
Table Major Company List of Standardization Of Cancer Treatment MRNA Vaccine
3.1.2 Individualized Cancer Treatment MRNA Vaccine
Table Major Company List of Individualized Cancer Treatment MRNA Vaccine
3.1.3 Infectious Disease Treatment MRNA Vaccine
Table Major Company List of Infectious Disease Treatment MRNA Vaccine
3.1.4 Infection Prevention MRNA Vaccine
Table Major Company List of Infection Prevention MRNA Vaccine
3.2 Market Size
Table Global mRNA Vaccines & Therapeutics Market 2017-2021, by Type, in USD Million
Figure Global mRNA Vaccines & Therapeutics Market Growth 2017-2021, by Type, in USD Million
Table Global mRNA Vaccines & Therapeutics Market 2017-2021, by Type, in Volume
Figure Global mRNA Vaccines & Therapeutics Market Growth 2017-2021, by Type, in Volume
3.3 Market Forecast
Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2027, by Type, in USD Million
Table Global mRNA Vaccines & Therapeutics Market Forecast 2021-2027, by Type, in Volume
4 Major Companies List
4.1 Argos Therapeutics (Company Profile, Sales Data etc.)
4.1.1 Argos Therapeutics Profile
Table Argos Therapeutics Overview List
4.1.2 Argos Therapeutics Products & Services
4.1.3 Argos Therapeutics Business Operation Conditions
Table Business Operation of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 AstraZeneca (Company Profile, Sales Data etc.)
4.2.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.2.2 AstraZeneca Products & Services
4.2.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bayer (Company Profile, Sales Data etc.)
4.3.1 Bayer Profile
Table Bayer Overview List
4.3.2 Bayer Products & Services
4.3.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 BioNTech (Company Profile, Sales Data etc.)
4.4.1 BioNTech Profile
Table BioNTech Overview List
4.4.2 BioNTech Products & Services
4.4.3 BioNTech Business Operation Conditions
Table Business Operation of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.5.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.5.2 Boehringer Ingelheim Products & Services
4.5.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 CRISPR Therapeutics (Company Profile, Sales Data etc.)
4.6.1 CRISPR Therapeutics Profile
Table CRISPR Therapeutics Overview List
4.6.2 CRISPR Therapeutics Products & Services
4.6.3 CRISPR Therapeutics Business Operation Conditions
Table Business Operation of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 CureVac (Company Profile, Sales Data etc.)
4.7.1 CureVac Profile
Table CureVac Overview List
4.7.2 CureVac Products & Services
4.7.3 CureVac Business Operation Conditions
Table Business Operation of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 eTheRNA immunotherapies (Company Profile, Sales Data etc.)
4.8.1 eTheRNA immunotherapies Profile
Table eTheRNA immunotherapies Overview List
4.8.2 eTheRNA immunotherapies Products & Services
4.8.3 eTheRNA immunotherapies Business Operation Conditions
Table Business Operation of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Ethris (Company Profile, Sales Data etc.)
4.9.1 Ethris Profile
Table Ethris Overview List
4.9.2 Ethris Products & Services
4.9.3 Ethris Business Operation Conditions
Table Business Operation of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 GlaxoSmithKline Vaccines (Company Profile, Sales Data etc.)
4.10.1 GlaxoSmithKline Vaccines Profile
Table GlaxoSmithKline Vaccines Overview List
4.10.2 GlaxoSmithKline Vaccines Products & Services
4.10.3 GlaxoSmithKline Vaccines Business Operation Conditions
Table Business Operation of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 In-Cell-Art (Company Profile, Sales Data etc.)
4.11.1 In-Cell-Art Profile
Table In-Cell-Art Overview List
4.11.2 In-Cell-Art Products & Services
4.11.3 In-Cell-Art Business Operation Conditions
Table Business Operation of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Intellia Therapeutics (Company Profile, Sales Data etc.)
4.12.1 Intellia Therapeutics Profile
Table Intellia Therapeutics Overview List
4.12.2 Intellia Therapeutics Products & Services
4.12.3 Intellia Therapeutics Business Operation Conditions
Table Business Operation of Intellia Therapeutics (Sales Revenue, Cost, Gross Margin)
4.13 Janssen (Company Profile, Sales Data etc.)
4.13.1 Janssen Profile
Table Janssen Overview List
4.13.2 Janssen Products & Services
4.13.3 Janssen Business Operation Conditions
Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Kernal Biologics (Company Profile, Sales Data etc.)
4.14.1 Kernal Biologics Profile
Table Kernal Biologics Overview List
4.14.2 Kernal Biologics Products & Services
4.14.3 Kernal Biologics Business Operation Conditions
Table Business Operation of Kernal Biologics (Sales Revenue, Cost, Gross Margin)
4.15 MaxCyte (Company Profile, Sales Data etc.)
4.15.1 MaxCyte Profile
Table MaxCyte Overview List
4.15.2 MaxCyte Products & Services
4.15.3 MaxCyte Business Operation Conditions
Table Business Operation of MaxCyte (Sales Revenue, Cost, Gross Margin)
4.16 Moderna Therapeutics (Company Profile, Sales Data etc.)
4.16.1 Moderna Therapeutics Profile
Table Moderna Therapeutics Overview List
4.16.2 Moderna Therapeutics Products & Services
4.16.3 Moderna Therapeutics Business Operation Conditions
Table Business Operation of Moderna Therapeutics (Sales Revenue, Cost, Gross Margin)
4.17 Novartis (Company Profile, Sales Data etc.)
4.17.1 Novartis Profile
Table Novartis Overview List
4.17.2 Novartis Products & Services
4.17.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin)
4.18 PhaseRx (Company Profile, Sales Data etc.)
4.18.1 PhaseRx Profile
Table PhaseRx Overview List
4.18.2 PhaseRx Products & Services
4.18.3 PhaseRx Business Operation Conditions
Table Business Operation of PhaseRx (Sales Revenue, Cost, Gross Margin)
4.19 Precision NanoSystems (Company Profile, Sales Data etc.)
4.19.1 Precision NanoSystems Profile
Table Precision NanoSystems Overview List
4.19.2 Precision NanoSystems Products & Services
4.19.3 Precision NanoSystems Business Operation Conditions
Table Business Operation of Precision NanoSystems (Sales Revenue, Cost, Gross Margin)
4.20 RaNa Therapeutics (Company Profile, Sales Data etc.)
4.20.1 RaNa Therapeutics Profile
Table RaNa Therapeutics Overview List
4.20.2 RaNa Therapeutics Products & Services
4.20.3 RaNa Therapeutics Business Operation Conditions
Table Business Operation of RaNa Therapeutics (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global mRNA Vaccines & Therapeutics Sales Revenue 2017-2021, by Company, in USD Million
Table Global mRNA Vaccines & Therapeutics Sales Revenue Share 2017-2021, by Company, in USD Million
Figure Global mRNA Vaccines & Therapeutics Sales Revenue Share in 2021, by Company, in USD Million
Table Global mRNA Vaccines & Therapeutics Sales Volume 2017-2021, by Company, in Volume
Table Global mRNA Vaccines & Therapeutics Sales Volume Share 2017-2021, by Company, in Volume
Figure Global mRNA Vaccines & Therapeutics Sales Volume Share in 2021, by Company, in Volume
5.2 Regional Market by Company
Figure North America mRNA Vaccines & Therapeutics Market Concentration, in 2021
Figure Europe mRNA Vaccines & Therapeutics Market Market Concentration, in 2021
Figure Asia-Pacific mRNA Vaccines & Therapeutics MMarket Concentration, in 2021
Figure South America mRNA Vaccines & Therapeutics Market Concentration, in 2021
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Concentration, in 2021
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospital
Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2017-2021, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Hospital, 2017-2021, in Volume
6.1.2 Demand in Clinic
Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2017-2021, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Clinic, 2017-2021, in Volume
6.1.3 Demand in Others
Figure mRNA Vaccines & Therapeutics Demand in Others, 2017-2021, in USD Million
Figure mRNA Vaccines & Therapeutics Demand in Others, 2017-2021, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2027, by Application, in USD Million
Figure mRNA Vaccines & Therapeutics Market Growth 2021-2027, by Application, in USD Million
Figure mRNA Vaccines & Therapeutics Market Share in 2027, by Application, in USD Million
Table mRNA Vaccines & Therapeutics Demand Forecast 2021-2027, by Application, in Volume
Table mRNA Vaccines & Therapeutics Market Growth 2021-2027, by Application, in Volume
Table mRNA Vaccines & Therapeutics Market Share in 2027, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table mRNA Vaccines & Therapeutics Production 2017-2021, by Region, in USD Million
Table mRNA Vaccines & Therapeutics Production 2017-2021, by Region, in Volume
7.2 Regional Market
Table Global mRNA Vaccines & Therapeutics Market 2017-2021, by Region, in USD Million
Table Global mRNA Vaccines & Therapeutics Market Share 2017-2021, by Region, in USD Million
Table Global mRNA Vaccines & Therapeutics Market 2017-2021, by Region, in Volume
Table Global mRNA Vaccines & Therapeutics Market Share 2017-2021, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in USD Million
Figure North America mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in USD Million
Table North America mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in USD Million
Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in USD Million
Table Europe mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in USD Million
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in USD Million
Table Asia-Pacific mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in USD Million
Figure South America mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in USD Million
Table South America mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in USD Million
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Growth 2017-2021, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in USD Million
Table Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2017-2021, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table mRNA Vaccines & Therapeutics Market Forecast 2021-2027, by Region, in USD Million
Table mRNA Vaccines & Therapeutics Market Forecast 2021-2027, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

Direct Purchase
Your perfect start with Stats And Research


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo

You may also be lnterested in..

Stats And Research Copyright © 2022 .